GSA Capital Partners LLP Sells 3,878 Shares of Agilent Technologies, Inc. $A

GSA Capital Partners LLP reduced its position in Agilent Technologies, Inc. (NYSE:A) by 44.5% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 4,843 shares of the medical research company’s stock after selling 3,878 shares during the period. GSA Capital Partners LLP’s holdings in Agilent Technologies were worth $643,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in A. State Street Corp grew its stake in shares of Agilent Technologies by 1.9% during the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after acquiring an additional 241,029 shares during the period. Geode Capital Management LLC raised its stake in Agilent Technologies by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after acquiring an additional 25,139 shares during the period. Morgan Stanley lifted its holdings in Agilent Technologies by 15.9% during the fourth quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after purchasing an additional 692,202 shares during the last quarter. Norges Bank purchased a new stake in Agilent Technologies during the fourth quarter valued at about $549,158,000. Finally, Cantillon Capital Management LLC boosted its position in Agilent Technologies by 0.8% during the fourth quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock worth $423,945,000 after purchasing an additional 23,493 shares during the period.

Agilent Technologies Stock Up 0.7%

Shares of NYSE A opened at $156.50 on Friday. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The company has a market cap of $44.20 billion, a P/E ratio of 31.43, a P/E/G ratio of 2.75 and a beta of 1.25. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The business has a 50-day simple moving average of $136.98 and a two-hundred day simple moving average of $126.00.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the prior year, the business posted $1.31 earnings per share. The company’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on A. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Royal Bank Of Canada started coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target on the stock. Sanford C. Bernstein initiated coverage on shares of Agilent Technologies in a report on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective for the company. Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Finally, Piper Sandler initiated coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price on the stock. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.